tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Income Statement

Compare
1,829 Followers

Traws Pharma Income Statement

Last quarter (Q3 2024), Traws Pharma's total revenue was $57.00K, a decrease of 0.00% from the same quarter last year. In Q3, Traws Pharma's net income was $-8.47M. See Traws Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 226.00K$ 226.00K$ 226.00K$ 231.00K$ 2.18M
Gross Profit
$ 210.00K$ 212.00K$ 212.00K$ 231.00K$ 2.18M
Operating Expenses
$ 20.51M$ 19.85M$ 16.72M$ 25.22M$ 23.87M
Depreciation and Amortization
$ 16.00K$ 14.00K$ 14.00K$ 13.00K$ 14.00K
EBITDA
$ -20.28M$ -19.61M$ -16.48M$ -24.98M$ -21.68M
Operating Income
$ -20.30M$ -19.63M$ -16.50M$ -24.99M$ -21.70M
Other Income/Expenses
$ 1.35M$ 663.00K$ 333.00K$ -160.00K$ 206.00K
Pretax Income
$ -18.95M$ -18.96M$ -16.16M$ -25.15M$ -21.49M
Net Income
$ -18.95M$ -18.96M$ -16.16M$ -25.16M$ -21.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.90$ -0.91$ -0.96$ -2.17$ -22.42
Diluted EPS
$ -0.90$ -0.91$ -0.96$ -2.17$ -22.42
Weighted Average Shares Outstanding
20.99M 20.91M 16.83M 11.60M 958.97K
Weighted Average Shares Outstanding (Diluted)
20.99M 20.91M 16.83M 11.60M 958.97K
Currency in USD

Traws Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis